Clinical Trial Update: Trastuzumab and Vinorelbine in Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating trastuzumab with vinorelbine in advanced/metastatic breast cancer has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Navelbine (vinorelbine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer, Metastatic Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-05-24